{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T14:26:16Z","timestamp":1793888776847,"version":"4.8.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,30]],"date-time":"2020-11-30T00:00:00Z","timestamp":1606694400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,11,30]],"date-time":"2020-11-30T00:00:00Z","timestamp":1606694400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1186\/s13054-020-03388-2","type":"journal-article","created":{"date-parts":[[2020,11,30]],"date-time":"2020-11-30T17:02:38Z","timestamp":1606755758000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["How I approach membrane lung dysfunction in patients receiving ECMO"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8662-5911","authenticated-orcid":false,"given":"Bishoy","family":"Zakhary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leen","family":"Vercaemst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip","family":"Mason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta V.","family":"Antonini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Lorusso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Brodie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,30]]},"reference":[{"issue":"6","key":"3388_CR1","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1001\/jama.2019.9302","volume":"322","author":"D Brodie","year":"2019","unstructured":"Brodie D, Slutsky AS, Combes A. Extracorporeal life support for adults with respiratory failure and related indications: a review. JAMA. 2019;322(6):557\u201368.","journal-title":"JAMA"},{"key":"3388_CR2","unstructured":"Extracorporeal Life Support Organization. ECLS registry report: international summary. https:\/\/www.elso.org\/Registry\/Statistics\/InternationalSummary.aspx. Accessed 4 August 2020."},{"issue":"6","key":"3388_CR3","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1097\/MAT.0000000000000133","volume":"60","author":"C Dornia","year":"2014","unstructured":"Dornia C, Philipp A, Bauer S, Lubnow M, Muller T, Lehle K, et al. Analysis of thrombotic deposits in extracorporeal membrane oxygenators by multidetector computed tomography. ASAIO J. 2014;60(6):652\u20136.","journal-title":"ASAIO J"},{"key":"3388_CR4","doi-asserted-by":"publisher","first-page":"352","DOI":"10.3389\/fmed.2018.00352","volume":"5","author":"AJ Doyle","year":"2018","unstructured":"Doyle AJ, Hunt BJ. Current understanding of how extracorporeal membrane oxygenators activate haemostasis and other blood components. Front Med (Lausanne). 2018;5:352.","journal-title":"Front Med (Lausanne)"},{"key":"3388_CR5","first-page":"30","volume-title":"Extracorporeal Membrane Oxygenation: Advances in Therapy","author":"TM Maul","year":"2016","unstructured":"Maul TM, Massicotte MP, Wearden PD. ECMO biocompatibility: surface coatings, anticoagulation, and coagulation monitoring. In: Firstenberg MS, editor. Extracorporeal Membrane Oxygenation: Advances in Therapy. Croatia: IntechOpen; 2016. p. 30\u20135."},{"issue":"12","key":"3388_CR6","doi-asserted-by":"publisher","first-page":"e112316","DOI":"10.1371\/journal.pone.0112316","volume":"9","author":"M Lubnow","year":"2014","unstructured":"Lubnow M, Philipp A, Foltan M, Bull Enger T, Lunz D, Bein T, et al. Technical complications during veno-venous extracorporeal membrane oxygenation and their relevance predicting a system-exchange\u2013retrospective analysis of 265 cases. PLoS ONE. 2014;9(12):e112316.","journal-title":"PLoS ONE"},{"issue":"4","key":"3388_CR7","doi-asserted-by":"publisher","first-page":"200","DOI":"10.5301\/ijao.5000498","volume":"39","author":"SM Hastings","year":"2016","unstructured":"Hastings SM, Deshpande SR, Wagoner S, Maher K, Ku DN. Thrombosis in centrifugal pumps: location and composition in clinical and in vitro circuits. Int J Artif Organs. 2016;39(4):200\u20134.","journal-title":"Int J Artif Organs"},{"issue":"6","key":"3388_CR8","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1097\/MAT.0b013e318186a807","volume":"54","author":"K Lehle","year":"2008","unstructured":"Lehle K, Philipp A, Gleich O, Holzamer A, Muller T, Bein T, et al. Efficiency in extracorporeal membrane oxygenation-cellular deposits on polymethylpentene membranes increase resistance to blood flow and reduce gas exchange capacity. ASAIO J. 2008;54(6):612\u20137.","journal-title":"ASAIO J"},{"issue":"Suppl 5","key":"3388_CR9","doi-asserted-by":"publisher","first-page":"S596","DOI":"10.21037\/jtd.2017.10.05","volume":"10","author":"F Epis","year":"2018","unstructured":"Epis F, Belliato M. Oxygenator performance and artificial-native lung interaction. J Thorac Dis. 2018;10(Suppl 5):S596\u2013605.","journal-title":"J Thorac Dis"},{"issue":"1","key":"3388_CR10","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1177\/0267659120906767","volume":"35","author":"B Zakhary","year":"2020","unstructured":"Zakhary B, Sheldrake J, Pellegrino V. Extracorporeal membrane oxygenation and V\/Q ratios: an ex vivo analysis of CO2 clearance within the Maquet Quadrox-iD oxygenator. Perfusion. 2020;35(1):29\u201333.","journal-title":"Perfusion."}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-020-03388-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13054-020-03388-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-020-03388-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,30]],"date-time":"2020-11-30T17:04:03Z","timestamp":1606755843000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-020-03388-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,30]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["3388"],"URL":"https:\/\/doi.org\/10.1186\/s13054-020-03388-2","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,30]]},"assertion":[{"value":"14 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Leen Vercaemst is consultant for Medtronic for conducting\/coordinating EMEA region ECMO trainings. Dr. Lorusso is consultant for Medtronic and LivaNova and is on the medical advisory board for Eurosets (all honoraria are paid at the university). Dr. Brodie receives research support from ALung Technologies. He has been on the medical advisory boards for Baxter, Abiomed, Xenios and Hemovent. No other authors report conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"671"}}